Periprocedural Myocardial Infarction: the Role of Human Neutrophil Peptide-1 to 3

NCT02591264 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2015-10-29

No results posted yet for this study

Summary

The aim of this study is to determine the role of human neutrophil peptide-1 to 3 in the occurrence of periprocedural myocardial infarction.

Conditions

  • Coronary Thrombosis

Interventions

OTHER

Blood sample

Blood sample drawn from participants for analysis of neutrophil peptide level

Sponsors & Collaborators

  • Hillel Yaffe Medical Center

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02591264 on ClinicalTrials.gov